GAMMA Investing’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.4K Buy
1,197
+128
+12% +$2.72K ﹤0.01% 2793
2026
Q2
$23.1K Buy
1,069
+259
+32% +$4.81K ﹤0.01% 2763
2026
Q1
$13.8K Sell
810
-204
-20% -$3.47K ﹤0.01% 2898
2025
Q4
$19K Buy
1,014
+300
+42% +$4.53K ﹤0.01% 2646
2025
Q3
$9.13K Buy
714
+386
+118% +$5.79K ﹤0.01% 2926
2025
Q2
$5.51K Sell
328
-860
-72% -$11.6K ﹤0.01% 3081
2025
Q1
$15.2K Buy
1,188
+1,155
+3,500% +$18.5K ﹤0.01% 2541
2024
Q4
$582 Buy
33
+6
+22% +$114 ﹤0.01% 3549
2024
Q3
$617 Sell
27
-41
-60% -$926 ﹤0.01% 3361
2024
Q2
$1.56K Buy
+68
New +$2.1K ﹤0.01% 2950

Other funds holding NRC

GAMMA Investing's NRC Position: Q3 2026 in Review

GAMMA Investing increased its NRC Health Common Stock (NRC) stake by 12% in Q3 2026, buying an estimated $2.72K and bringing the position to 1,197 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2793.

GAMMA Investing first reported a position in NRC in Q2 2024 and has held it in 10 quarters since. 11 funds tracked by Wall St. Rank hold NRC as of Q3 2026.

  • GAMMA Investing held 1,197 shares of NRC Health Common Stock worth $25.4K as of Q3 2026.
  • GAMMA Investing bought 128 NRC Health Common Stock shares in Q3 2026, an estimated $2.72K.
  • NRC Health Common Stock made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2793 holding.
  • GAMMA Investing first reported a position in NRC Health Common Stock in Q2 2024 and has held it in 10 quarters since.
  • 11 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.